For decades, geneticists have known that most common illnesses are not caused by a single rogue gene but by intricate ...

This year saw notable progress in head and neck cancers, Huntington's disease, personalized genetic therapy, and heart ...

Researchers from Nazarbayev University's National Laboratory created the first large-scale, high-quality genotyping dataset ...

Genetic engineering is moving from the lab bench into clinics, farms, and even family planning decisions, promising to change how we prevent disease, age, and define human potential. The same tools ...

All-RNA, non-viral, LNP-based PRINT™ platform is designed to develop safer, durable, one-time therapies for a broad range of unmet needsAddition is advancing a robust pipeline of PRINTed therapeutics ...

The Global Genomic Medicine Collaborative (G2MC) is an international action collaborative focused on the implementation of genomic medicine in clinical care. Arising from the 2014 Global Leaders in ...

The sequencing of the human genome has created an unprecedented opportunity to apply new knowledge and technology to improve human health. The goal of the CCTS Genomic & Precision Medicine Special ...

Artificial Intelligence (AI) is transforming the landscape of genomic medicine, unlocking opportunities to accelerate the discovery of relevant alterations, improve and democratise molecular ...

The critical work of those racing to cure rare pediatric diseases got an important shot in the arm today. Florida’s newly created Sunshine Genetics Consortium promises hope for children living with ...

Dr. David Buchner is an accomplished geneticist and educator whose career spans more than two decades of research and leadership in human genetics, metabolic disease, and computational genomics. He ...

Black patients and patients from socioeconomically disadvantaged neighborhoods are dramatically under-represented in genetics ...